Timothy Brown – learning from the Berlin patient
A number of papers are carrying stories about the prospects for an HIV cure - this commentary in The Lancet explains what the Berlin patient has taught us.
News
Read More » Timothy Brown – learning from the Berlin patient
SA docs welcome US approval of ARV as a prevention tool
South African HIV Clinicians have welcomed an announcement that the Food and Drug Administration (FDA) in the United States has approved the use of an antiretroviral by sexually active HIV-negative men and women as a method of reducing the risk HIV infection in adults.
Drugs Used To Treat HIV Also Reduce Risk of HIV Infection
People at high risk of HIV infection can reduce their risk of acquiring the disease by taking antiretroviral drugs, according to Cochrane researchers.
New study on microbicide vaginal ring to prevent HIV
A new clinical trial in the area of HIV prevention for women is underway in South Africa. It is known as 'The Ring Study' and it will test the long-term safety and preventive efficacy of an antiretroviral drug, dapivirine, when this is contained in a vaginal ring that releases the drug into the vagina in a sustained manner.
Mouse studies show how body helps TB survive
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could -- paradoxically -- shorten treatment time for the highly contagious lung infection, according to new research from Johns Hopkins Children's Center and the Center for TB Research.
Counsellors strike, patients suffer Living with AIDS # 521
Some 7 500 HIV counsellors and community health care workers in Gauteng have downed tools after not being paid for months.
Stavudine trial causes split
AIDS activists and researchers are at loggerheads over the planned South African trial of a lower dose version of the controversial antiretroviral stavudine, which has in the past been responsible for debilitating side-effects in HIV patients.
Tenofovir shortage almost over
The national health department has contracted additional pharmaceutical manufacturers to make up the critical shortage of the antiretroviral tenofovir across the country.
US moving towards a-pill-a-day HIV prevention
HIV prevention groups in the United States have hailed the recommendation by an FDA Advisory Committee that emtricitabine/tenofovir disoproxil fumarate (TDF/FTC or Truvada) be approved for use as pre-exposure prophylaxis (PrEP) among sexually active adult men and women.
Malaria & HIV Living with AIDS # 514
Malaria symptoms are often mistaken for the common flu and many people leave them unchecked. This often leads to severe illness and death, especially in people who have HIV.
SA exceeds NSP targets
One third of all HIV infected South Africans are accessing antiretroviral therapy (ART), far exceeding the enrolment targets of the country's National Strategic Plan (NSP) for 2007 to 2011.
Activists call for new TB machine costs to be dropped
Activists have sent another letter to Cepheid, the manufacturer of the revolutionary GeneXpert multi-drug resistant TB diagnostic machine, urging them to bring down the price of their products so that more people can access this lifesaving test.
KZN rolls out dodgy circumcision Klamp despite questions
HIV activists and senior doctors have called for an urgent investigation into the continued rollout of a controversial male circumcision device in KwaZulu-Natal.
National immunisation drive
Pretoria - The Department of Health has called on parents and caregivers to take their children for their immunisations against pneumococcal diseases during a four-month Catch-Up immunisation campaign.
SADC countries battling to reach HIV positive people
Only one in three Mozambicans, Tanzanians and Zimbabweans who need antiretroviral medicine are getting it, according to new research.